GSK and Pfizer "Agreement" Creates Specialist HIV Company

Thu, 04/16/2009 - 4:35am
GlaxoSmithKline and Pfizer today announced an "innovative agreement" to pooltheir HIV assets creating a new world-leading, specialist HIV company.The deal will see the drug giants combine their existing HIV product andtheir pipelines with GSK holding 85% of the company and Pfizer 15%.The deal will be marginally dilutive to GSK earnings in the first twoyears but in a video interview Group CEO Andrew Witty said there were longerterm benefits for GSK shareholders. "Today we own 100 per cent of a pipeline with three assets in it.Tomorrow we'll own 85 per cent of a pipeline with somewhere between five andseven assets in it." The GSK boss said he was also committed to maximising the cost savingsfrom the combination.

Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.